Skip to main content

Crohn's Disease - Acute News

Risankizumab Noninferior, Superior to Ustekinumab for Crohn Disease

WEDNESDAY, July 17, 2024 – For patients with moderate-to-severe Crohn disease, risankizumab is noninferior to ustekinumab for clinical remission at week 24 and is superior for endoscopic remission...

'Microrobot' Pills Eased IBD in Mice, Paving Way for Human Testing

FRIDAY, June 28, 2024 – A new "microrobot" pill may help tame inflammatory bowel disease (IBD), a new study in mice suggests. The pill significantly reduced IBD symptoms in mice and promoted the...

No Link Seen Between Exposure to Immunosuppressive Therapy, Cancer in IBD Patients

TUESDAY, June 11, 2024 – There is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD)...

Risk for Most Cardiovascular Diseases No Higher With Inflammatory Bowel Disease

FRIDAY, May 3, 2024 – Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD, although the risk...

Study IDs Risk Factors for Extraintestinal Manifestations of IBD

WEDNESDAY, April 17, 2024 – Certain demographic, clinical, and genetic factors heighten the risk for extraintestinal manifestations (EIMs) with inflammatory bowel disease (IBD), according to a study...

Top-Down Treatment Superior for Crohn Disease

TUESDAY, March 5, 2024 – Top-down treatment for Crohn disease (combination infliximab plus immunomodulator) achieves substantially better outcomes than accelerated step-up treatment, according to a...

Treating Crohn's Sooner, More Aggressively Greatly Improves Outcomes: Study

MONDAY, Feb. 26, 2024 – In a finding that suggests sooner is better than later, a new trial shows that giving advanced treatment early to Crohn’s patients can dramatically improve their gut health. A...

Higher Use of Any Rx Medications Seen Years Before IBD Diagnosis

FRIDAY, Jan. 19, 2024 – Individuals with inflammatory bowel disease (IBD) universally show increased prescription medication use years before diagnosis, according to a study published in the...

Malnutrition Often Seen in Patients Treated for IBD

FRIDAY, Jan. 12, 2024 – Some patients seen in an inflammatory bowel disease (IBD) clinic screen positive for malnutrition, according to a research letter published online Nov. 20 in Gastro Hep ...

Persistent Fluorinated Chemicals Tied to Higher Risk for Inflammatory Bowel Disease

FRIDAY, Jan. 12, 2024 – Perfluoroalkyl and polyfluoroalkyl substance (PFAS) exposure is associated with later occurrence of inflammatory bowel disease (IBD), according to a research letter published...

Inflammatory Bowel Disease Phenotypes Vary by Race, Birthplace

MONDAY, Jan. 8, 2024 – For patients with inflammatory bowel disease (IBD), phenotype varies by race, and foreign-born patients of all races have later onset and milder disease, according to a study...

Crohn's, Colitis Vary by Race, Gender

FRIDAY, Jan. 5, 2023 – Crohn's disease and ulcerative colitis show different patterns of incidence by race, gender and even place of birth, a new U.S. study finds. The two illnesses are each...

Changes in Biochemical, Hematological Parameters Seen Before IBD Diagnosis

MONDAY, Dec. 11, 2023 – Changes in multiple biochemical and hematological parameters occur up to eight years before diagnosis of Crohn disease and up to three years before diagnosis of ulcerative...

Histologic Inflammation With IBD Tied to Serious Infections

FRIDAY, Dec. 8, 2023 – Histologic inflammation with inflammatory bowel disease (IBD) is an independent risk factor for serious infections, according to a study published online Oct. 29 in Clinical ...

Higher Visceral Adipose Tissue May Need Higher Infliximab Levels for IBD Remission

WEDNESDAY, Nov. 15, 2023 – Patients with inflammatory bowel disease (IBD) and high visceral adipose tissue (VAT) may have more difficulty achieving higher infliximab levels necessary to achieve...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Crohn's Disease

Related drug support groups

prednisone, metronidazole, Humira, ciprofloxacin, betamethasone, hydrocortisone, cortisone, Remicade, prednisolone, Stelara, adalimumab, dexamethasone, budesonide